Janssen is a major partner with Crohn’s & Colitis Australia on its national awareness month, incorporating World Inflammatory Bowel Disease (IBD) Day every 19 May, to raise awareness and support for the people around the world living with Crohn’s disease and ulcerative colitis (UC).

At Janssen, we are focused on supporting patients with therapies to treat Crohn’s disease and UC, and advancing science to one day intercept and cure IBD.  We partner with patient organisations and health advocates around the world, promoting IBD awareness and earlier diagnosis and treatment, to address the lifelong physical, social and psychological burdens often associated with these inflammatory diseases.

On World IBD Day, we commend our advocacy partners for their efforts to bring greater understanding and recognition of Crohn’s disease and Ulcerative Colitis around the world.

At Janssen, we collaborate with the world for the health of everyone in it.